These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 35979263)

  • 1. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
    Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
    World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway.
    Li X; Ma XL; Nan Y; Du YH; Yang Y; Lu DD; Zhang JF; Chen Y; Zhang L; Niu Y; Yuan L
    World J Gastroenterol; 2023 Jun; 29(23):3622-3644. PubMed ID: 37398884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
    Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
    World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.
    Yuan L; Li JX; Yang Y; Chen Y; Ma TT; Liang S; Bu Y; Yu L; Nan Y
    World J Gastroenterol; 2021 Apr; 27(16):1785-1804. PubMed ID: 33967557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.
    Liang R; Chen W; Chen XY; Fan HN; Zhang J; Zhu JS
    Pathol Res Pract; 2021 Feb; 218():153318. PubMed ID: 33370709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation.
    Li X; Du Y; Huang S; Yang Y; Lu D; Zhang J; Chen Y; Zhang L; Nan Y; Yuan L
    Aging (Albany NY); 2023 May; 15(9):3839-3856. PubMed ID: 37171392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18β-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation-regulated TLR2 signaling pathway.
    Cao D; Wu Y; Jia Z; Zhao D; Zhang Y; Zhou T; Wu M; Zhang H; Tsukamoto T; Oshima M; Jiang J; Cao X
    Carcinogenesis; 2019 Apr; 40(2):234-245. PubMed ID: 30364936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the
    Gu P; Huang W; Lu W; Shu P
    Discov Med; 2024 May; 36(184):923-935. PubMed ID: 38798252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis.
    Zhang L; Lu P; Yan L; Yang L; Wang Y; Chen J; Dai J; Li Y; Kang Z; Bai T; Xi Y; Xu J; Sun G; Yang T
    Am J Pathol; 2019 May; 189(5):1105-1120. PubMed ID: 30862482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis.
    Li M; Cai O; Yu Y; Tan S
    Phytomedicine; 2022 Feb; 96():153903. PubMed ID: 35026514
    [TBL] [Abstract][Full Text] [Related]  

    Qian J; Li J; Jia J; Jin X; Yu D; Guo C; Xie B; Qian L
    Afr J Tradit Complement Altern Med; 2016; 13(4):145-156. PubMed ID: 28852730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRPL35 Induces Proliferation, Invasion, and Glutamine Metabolism in NSCLC Cells by Upregulating SLC7A5 Expression.
    Hou W; Chen J; Wang Y
    Clin Respir J; 2024 Jul; 18(7):e13799. PubMed ID: 38987867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of polyphyllin in the treatment of gastric cancer was verified based on network pharmacology and experimental validation.
    Lu D; Yuan L; Ma X; Meng F; Xu D; Jia S; Wang Z; Li Y; Zhang Z; Nan Y
    Heliyon; 2024 May; 10(10):e31452. PubMed ID: 38831826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of CCNE1 expression suppresses cell proliferation and sensitizes gastric carcinoma cells to Cisplatin.
    Zhang C; Zhu Q; Gu J; Chen S; Li Q; Ying L
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway.
    Wang J; Wang Y; Wang J; Zhang S; Yu Z; Zheng K; Fu Z; Wang C; Huang W; Chen J
    Bioengineered; 2022 May; 13(5):13970-13985. PubMed ID: 35723050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
    Ge N; Jiang YY; Pan ZP; Wan J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
    Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
    Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.